Amneal Pharmaceuticals (AMRX) Deferred Taxes (2017 - 2019)

Amneal Pharmaceuticals' Deferred Taxes history runs 3 years deep, the most recent figure standing at $33000.0 for Q4 2019.

• On a quarterly basis, Deferred Taxes rose 110.06% year-over-year to $33000.0 in Q4 2019; TTM through Sep 2020 was $33000.0, a 99.99% decrease from a year earlier, with the FY2019 full-year figure at $371.7 million, up 4038.09% from the prior year.
• Deferred Taxes fell to $33000.0 in Q4 2019 per AMRX's latest filing, from $389.9 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $389.9 million in Q3 2019 and bottomed at -$14.5 million in Q2 2018.
• The 3-year median for Deferred Taxes is -$420000.0 (2018), against an average of $36.2 million.
• Biggest YoY gain for Deferred Taxes was 6528.56% in 2019; the steepest drop was 1830.47% in 2019.
• Year by year, Deferred Taxes stood at $534000.0 in 2017, then slumped by 161.42% to -$328000.0 in 2018, then surged by 110.06% to $33000.0 in 2019.
• Per Business Quant, the three latest AMRX Deferred Taxes figures stand at $33000.0 (Q4 2019), $389.9 million (Q3 2019), and -$8.3 million (Q2 2019).